| Parameters |
Cases (N=26) |
Controls (N=78 ) |
COR(95% CI) |
p value |
AOR (95% CI) |
pvalue |
| BMI |
<18.5 |
20 |
41 |
3.0 (1.1-8.3) |
0.033 |
3.7(1.1-12.3) |
0.033 |
| ≥18.5 |
6 |
37 |
1.0 |
|
|
|
| CD4+cell count |
<50 |
15 |
22 |
13.0(1.6-107.4) |
0.018 |
8.7 (1.0-79.1) |
0.054 |
| 51-100 |
4 |
18 |
4.2 (0.4-41.5) |
0.216 |
3.3 (0.3-38.1) |
0.332 |
| 101-200 |
6 |
19 |
6.0(0.7-54.8) |
0.112 |
4.1(0.4-46.6) |
0.200 |
| >200 |
1 |
19 |
1.0 |
|
|
|
| Type of TB |
SPPTB |
10 |
55 |
1.0 |
|
|
|
| SNPTB |
3 |
9 |
1.8 (0.4-7.9) |
0.419 |
1.8 (0.3-9.8) |
0.496 |
| EPTB |
13 |
14 |
5.1 (1.8-14.0) |
0.002 |
3.1(1.0-10.1) |
0.064 |
| Hepatitis B co-infection |
No |
19 |
74 |
1.0 |
|
|
|
| Yes |
7 |
4 |
6.8 (1.8-25.7) |
0.005 |
6.6(1.4-31.7) |
0.019 |
| WHO stage |
Stage 3 |
13 |
64 |
1.0 |
|
|
|
| Stage 4 |
13 |
14 |
2.8 (1.1-6.9) |
0.027 |
3.1(0.9-10.1) |
0.064 |
COR: Crude Odd Ratio, AOR: Adjusted Odd ratio, CI: Confidence Interval |
